Neuropharmacology Conference | Neuropharmacology Congress | Neurochemistry Conference | Neurological Disorders Conference | Human Brain Mapping Conference | Amsterdam | Netherlands | Europe

Theme: â€œExploring the challenges and recent innovations in Neuropharmacology and Neurochemistry"

Neuropharmaceutics 2022

Neuropharmaceutics 2022

We welcome you and appreciate your participation at the 27th International Conference on Neuropharmacology and Neurochemistry, which will be held during June 13-14, 2022. Conference will be organized around the theme of “Exploring the challenges and recent innovations in Neuropharmacology and Neurochemistry”.

Neuropharmacology and Neurochemistry webinar is a specific discussion to bring the innovative methods and also unite renowned Researchers and academicians concerned with neurology, neuroscience, cognition also Psychiatrist specialists, Public well-being professionals, Neuroscientists and Specialists to trade about innovative research and innovations. This webinar will pick up advanced knowledge in the field of Neuropharmacology and Neurochemistry. The purpose of the webinar is to provide a stage to Scholastics and specialists with the wide spectrum of disciplines on social change that is surrounded by technology and innovation. It’s the best opportunity to extent the knowledge worldwide.

Conference Series LLC Ltd invites all the applicants from all over the world to join towards Neuropharmacology and Neurochemistry Webinar which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

NEUROPHARMACEUTICS 2022 Invites and welcomes all the delegates, presenters, sponsors, and exhibitors from all over the realm. We are pleased to invite you all to join and register for the 27th International Conference on Neuropharmacology and Neurochemistry.

We invite you to join us at the Neuropharmacology and Neurochemistry Webinar, where you will be sure to have a meaningful experience with scholars from around the world.

NEUROPHARMACEUTICS 2022 is intended to honor prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in giving a strong professional development opportunity for primary career academicians by meeting experts to interchange and share their experiences on all aspects of Neuropharmacology and Neurochemistry.

Young Research’s Awards at NEUROPHARMACEUTICS 2022 for the Nomination:
Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the NEUROPHARMACEUTICS 2022.

YRF Registration benefits:

Young Scientist Award certificate and memento to the winners

NEUROPHARMACEUTICS 2022 delivers best Platform for your research through oral presentations.

Learn about career development with all the newest technologies by interacting.

Provide an opportunity for research interaction and established senior investigators across the world in the field of Neuropharmacology and Neurochemistry.

It’s a great opportunity for young researchers to learn about the research areas for increasing their research knowledge.

NEUROPHARMACEUTICS 2021 is a unique forum to bring together international eminent academics in the field of Neuropharmacology and Neurochemistry, Brain researchers, public health professionals, neuro scientists, neuro academic scientists, industry researchers, neuro scholars to talk about state of the art research and technologies.

Target Audience:

Neurologists and Directors
Physicians
Neuroscientists
Specialists
Researchers
Health care professionals
Professors
Industrial Experts
Neurosurgeons
Psychiatrist
Students from Academia in the research of Neurology
Mental Health
Neurobiologist
Neurological Surgeon
Neurologist
Neuroanatomist
Neuropathologist
Neuro pharmacologist
Neuro chemist
Neurophysiologist
Neuropsychologist
Psych biologist

Advantages of Participating at our Webinar

The Speaker's advantages and abstract pages in Google will be made visible worldwide on your profile under your name.
There are over three hundred thousand users and more over 50,000 views of our Abstract Library, bringing researchers and speeches into our webinar, on our comprehensive online advertising.
Meet hundreds of pioneers in neuropharmacology and neurochemistry who share thoughts.
All webinar participants would have another reason to participate in one-to-one meetings with distinguished speakers and renowned keynote speakers.
A rare opportunity to hear from the world's most influential neuropharmacology and neuroscience researcher at our keynote sessions.
Neuropharmaceutics 2021 webinar schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognized professionals.
Best Poster Award nominations
Award for Outstanding Young Researcher
Group Registration Advantages

Benefits of Participation for Speaker

Global awareness of the researchers' profile
Professional growth
Explore the latest state of the art analysis
Make long-term social and networking bonds •
An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
Learn a transition beyond your area of interest to learn more about new subjects and studies away from your core subject of Neuropharmacology and Neurochemistry.
We have distinctive networking, learning and enjoyable integration into a single package.

Benefits of Participation for Delegate

Professional Development-Improve understanding and knowledge.
Attendance at webinars supports rejuvenates and energies delegates.
Your involvement in our webinar will help with a new methodology and ideology that can be used to broaden the outcomes of businesses or industries.
Opportunities for Neuropharmaceutics 2021 researchers and experts in the same field to meet and exchange new ideas through an online webinar.

Benefit of Participation for Sponsor

Exposure to the international environment would increase the possibility of new companies.
Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of international participants.
Increase business by our webinar participants through lead generation.
It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and objective.
Webinars in Neuropharmacology and Neurochemistry provide opportunities for more attention and contemplation that could help you move your company to the next stage.
Benchmarking main organization plans and moving it forward.
Get feedback from trustworthy people at our webinar to your company questions and challenges.
On our webinar banner, website and other proceedings, branding and marketing content, the advertising logo of your company.

Benefit of Association for Collaborators

Nobody has these massive neurology visitors worldwide, this is the best forum for society to highlight.
Creating long-lasting peer relationships.
In our webinar banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.
Our event will have a great impact on your organization if we present your company's listings on the Global Business Forum.
Your representatives can network to update their knowledge and understanding of your organization and services with key webinar delegates.
Neuropharmacology and Neurochemistry advertising materials such as posters, brochures, pamphlets, services that will be circulated to hospitals, universities, society and researchers will be integrated with information.

Track 1: Neuropharmacology and Neurochemistry

Neurochemistry and Neuropharmacology is the learning of how drugs distress cellular function in the nervous system, and the neural mechanisms through which they impact behavior. There are two key branches of neuropharmacology are behavioral and molecular. Behavioral neuropharmacology emphases on the learning of how drugs affect human behavior (neuro psychopharmacology), with the study of how drug requirement and addiction affect the human brain.

Track 2: Molecular and cellular neurochemistry

Molecular and Cellular Neuroscience prints unique research of high significance covering all aspects of neurosciences specified by the broadest interpretation of the journal's title. In specific, the journal emphases on synaptic maintenance, de-organization and re-organization, neuron-glia communication, and de-/regenerative neurobiology. In accumulation, studies using animal models of disease with translational prospects and experimental methods with backward validation of disease signatures from human patients are welcome.

Track 3: Neurological Disorders and Stroke

Neurological disorders are pathologically well-defined as disorders that affect the brain as well as the nerves found throughout the human body and the spinal cord. There are many abnormalities happens in the brain: Structural, biochemical or electrical, spinal cord or other nerves can result in a range of symptoms.

Track 4: Clinical Neurophysiology and Stroke

Stroke is the most common reason of death and the leading source of acquired neurologic handicap. The clinical neurophysiology of stroke emphases on slow EEG potentials recorded in stroke. A clinical neurophysiologist is a neurologist who focuses in the diagnosis of nervous system disorders. Neurophysiologists do EEG (electroencephalography), EMG (electromyography), and other actions to calculate the function of the brain and nervous system.

Track 5: Alzheimer’s and Parkinson’s Diseases

Alzheimer's and Parkinson's are both neurological illnesses and these diseases are affected by damaged brain cells. In both circumstances can involve dementia, besides depression, anxiety, and sleep disturbances. These diseases can lead to psychotic symptoms such as delusions and hallucinations. Alzheimer's disease has clumps of two main proteins are beta-amyloid and tau. Clumps of beta-amyloid are termed plaques, and tau clumps are termed tangles. Parkinson's disease has Lewy bodies in main areas of the brain that control movement and Lewy bodies are collected of the protein alpha-syncline.

Track 6: Neuroimmunology and Neurological Infections

Neuroimmunology is a branch that combines neuroscience and neuroscience is the study of the nervous system and immunology is the study of the immune system. Neuroimmunologists discovers better understanding in the relations of these two complex systems during development, homeostasis and response to injuries. The most common neurological infections are: An inflammation of the brain and Encephalitis that can be created by either bacteria or virus. Meningitis is the inflammation of the membranes that enclose the brain and spinal cord, can be created by either bacteria or virus.

Track 7: Brain Injury and Behavioral Neuroscience

Traumatic brain injury is a misfortune of various causes, pathologies, and extremely varied and often multifaceted clinical presentations. Because of its preference for brain systems underlying cognitive and multifaceted behavioral operations, it may cause chronic and severe psychiatric illness that needs expert management. Traumatic brain injury is a typical for other neuropsychiatric disorders and may serve as an incubator of new thoughts for neurodegenerative disease.

Track 8: Neuropharmacology and genetic aspects of CNS function

Neuropharmacology is the learning of the effects of drugs on the nervous system and targeting to develop compounds to benefit humans with psychiatric and neurological disease. These contain Huntington's disease, myotonic dystrophy, Rett syndrome and fragile X syndrome. In these cases, the single-gene mutation causes certain neurons in the central and peripheral nervous system to develop abnormally and function poorly.

Track 9: Cognitive Neuroscience and Psychology

Cognitive neuroscience is the learning of how the brain enables the mind. Cognitive science uses the experimental approaches of cognitive psychology and artificial intelligence to create and test models of higher-level cognition such as thought and language. Cognitive neuroscience is study cognition from the level of cranial nerve and is a significant field of learning science. It is main focus on the neural mechanisms of perception, selective attention, memory, language, emotion and consciousness.

Track 10: CNS and Brain Disorders

Central nervous system diseases are also known as central nervous system disorders are a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system. Brain and nervous system problems are common. These neurological disorders include multiple sclerosis, Alzheimer's disease, Parkinson's disease, epilepsy, and stroke, and can affect memory and ability to perform daily activities.

Track 11: Neuroscience and Artificial Intelligence

The advances in artificial intelligence systems can contribute to advancing neuroscience and revealing brain secrets. This provides for better models for the simulation of the human brain by neuroscientists and researchers. Neural networks act as "virtual brains" that capture our brain's representation. The link between artificial intelligence and neuroscience can lead to an understanding of the brain mechanisms that generate human awareness.

Track 12: Neuroinformatics and Computational Neuroscience

The maintenance of neuroscience databases is facilitated by neuroinformatics. The area is related to development of analytical tools and computer models for the sharing of data, the integration of knowledge and the examination of neuroscience big data. Computational neuroscience includes the study by computer modelling and mathematical analysis of brain function. In computer scientists, they carry out research in which data is collected and computer models are created based on the brain's electric models and biological functions.

Track 13: Human Brain Mapping

Brain mapping is a series of neuroscience methods based on mapping (biological) amounts or properties to (human or non-human) space representations of the brain that produce maps. Brain mapping helps doctors understand a problem's source better. Knowing a problem source permits specific therapies. The anatomy of the brain is properly understood. Brain mapping gives information on brain and connectivity communication.

Track 14: Brain Stimulation and Imaging

Therapies for brain stimulation use directly with electricity to activate or inhibit the brain. Strom can be directly determined by electrodes implanted in the brain or by electrodes placed non-invasively on the scalp. Electricity can also be induced through the use of magnetic fields on the head. Brain imagery and brain stimulation have both enhanced our understanding of normal functional mechanisms and changes related to brain and mental illness. Brain encouragement has also shown promise to reduce brain and mental illness symptoms and allows hypotheses derived from data on brain imaging to be tested.

Track 15: Neurogenesis

Neurogenesis is the process through which neuronal stem cells are produced (NSCs). It takes place in all animal species except proliferous animals (sponges) and placozoans. The process of neurogenesis is the formation of new neurons in the brain. In certain brain areas after birth and throughout our lifetime, neurogenesis is essential when an embryo develops.

Track 16: Neurotherapeutics and Case Studies

Neurotherapy teaches a person to produce better EEG patterns with positive strength. The customer is connected to EEG sensors that measure brain activity during a neurofeedback session. Connect the sensors to a computer, and the EEG signals control simple computer games. A type of alternative therapy, specifically one type of biofeedback that uses real-time electromephalography (EEG) displays to illustrate brain activity, is neurotherapy also known as neurofeedback (NFB), EEG biofeedback, or brainwave education.

Track 17: Brain Structure and Function

The three principal parts of the brain are the Cerebrum, and brainstem. The cerebrum consists of the right and left hemispheres and is the largest portion of the brain. It performs higher functions such as touch interpretation, vision and hearing, as well as speech, thought, emotion, learning and control of the movement. In the human body, the brain is the most important organ. It controls and coordinates actions and reacting, allows us to think and feel, and enables us, all things that make us human, to have memories and feelings.

Track 18: Pre- and post-synaptic function

The presynaptic neuron is the information sending cell (i.e., transmits chemical messages). The postsynaptic neuron is the information cell (i.e., receives chemical messages). PNs are inhibited indirectly by presynaptic inhibition, which regulates the probability of ORN-PN releases, while the postsynaptic inhibition directly inhibits PN activity by hyperpolarizing the membrane potential of PNs. The physiological difference between the PNs is pre- and postsynaptic inhibition.

Track 19: Synapse formation and neurotransmitter receptors

Synapse formation is a highly regulated process which leads to the transmission and receipt of signals in morphologically separate subcellular structures at pre- and post-synaptic sites. A neurotransmitter receptor is a class of receptors that binds neurotransmitters specifically in contrast to other molecules. Neurotransmitter receptors receive signals in post synaptic cells that trigger electric signal by regulating ion channel activity.

Track 20: Synaptic Function and Dysfunction in Brain Diseases

Synaptic dysfunction results in cell-intrinsic molecular mechanism modifications or changes in surrounding biochemical processes. A synaptic dysfunction at an early or late stage is a common denominator of several diseases called synaptopathies. Synaptopathy is a popular term used to define the key characteristics of the psychiatric and neurodegenerative diseases. It suggests that synaptic disorders can be the major determinant of such brain diseases.

Track 21: Synaptic plasticity and memory

The hypothesis of the synaptic plasticity and memory asserts that the activity-dependent synaptic plasticity is induced during memory formation at appropriate synapse and is both essential and sufficient to encode and store the kind of memory mediated by the brain area in which it is observed. Memories are first stored in the hippocampus, where in seconds of the events to be remembered, synapses between excitatory neurons begin to develop new circuits. A relatively small number of synapses can increase its strength by binding neurons into a circuit that stores a new memory.

Track 22: Brain Pathology and Oncology Research

Pathology is the knowledge of disease or damage causes and effects. Pathology highlights disease elements: source, growth methods (pathogenesis), structural cell changes and alterations result. Oncology teaches neoplasms of the backbone and brains, most of which are very frightful and life-threatening (astrocytoma, glioma, glioblastoma multiform, ependymoma, pontine glioma, and brain stem tumours are among the most examples of these). Glioma of brainstem and pons, multiform Glioblastoma and high-grade (highly anaplastic) Astrocytoma are among the worst among malignant cancers of the brain.

Track 23: Stem Cells Role in Neuro-Biological Treatment

After nervous system injury neural stem cells provide the possibility of replacing the lost tissue. Stem cells may, partly by secreting growth factors, encourage host neural repair, and their regeneration-promoting activities may be altered through gene delivery. Stem cells are unique human cells, which can develop into many different types of cells. This can vary between muscle cells and brain cells. In certain cases, damaged tissues can also be repaired. Neural stem cells can replace lost tissue after injury to the nervous system. The host neural repair can be enhanced by stem cells partly through secreting growth factors and gene supply can modify their regeneration promotions.

Track 24: Neurobiology and Behaviors

NBB continues to innovate by using advanced imaging techniques to examine the extraordinary abilities of the mind. The faculty leads students to learn how the brain produces memories, thoughts, emotions and awareness. The brain is a meeting place between our genes and the environment where nature interacts and nurtures. It can affect our intellectual circuitry and biochemistry, as well as genetic controls. In turn, these neurobiological mechanisms can affect conduct.

Track 25: Neurorehabilitation and Neural Repair

Innovative and trustworthy reports on functional recovery from neurological injury and long-standing neurological care are provided by Neurorehabilitation and Neural Repair. The main focus of neurological rehabilitation is on disability. In many ways, neurological rehabilitation differs from other neurological branches. Rehabilitation is the education process of a person with a disability, which is aimed at helping him or her to cope as independently as possible with family, friends, work and leisure.

Track 26: Neuroendocrinology

Neuroendocrinology is the biologic branch (in particular the physiological one) which study the interplay between the nervous system and the endocrine system. In a process called neuroendocrine integration, nervous and endocrine systems often work together to regulate the physiological processes of the human body. The recognition that the brain controls the secretion of hypo physical hormones, especially the hypothalamus, and subsequently expanded to explore numerous interconnections between endocrine and nervous systems, led to a neuroendocrinology.

Track 27: Pediatric Neurology and Epilepsy

Children with diseases and conditions which affect the nervous system are diagnosed and treated by pediatric neurologists. Patients with head injuries, seizures or muscle weakness are also included. Epilepsy is a chronic disease causing recurring seizures without provocation. An attack is a sudden rush of brain electrical activity. Two major types of convulsions are present. Widespread convulsions affect the entire brain. Only one part of the brain is affected by focal or partial seizures.

Track 28: Neuroimaging and Diagnostic Techniques

Neuroimaging is a technology class which provides an array of structural anatomy and physiological or metabolic functions within the central and peripheral nervous system, directly or indirectly derived from visual representation. The technology of the neuroimaging—for example, CT, MRI, FMRI and positron emission tomography (PET)—provides both anatomical and functional nervous system visualization, which is a major advancement in modern medicine and the science of neuroscience. The methods of neuro-imaging include: neuroimaging.

Track 29: Neuromodulation

Neuromodulation is defined as a field of science, medicine and bioengineering, comprising both implantable and implantable electronic and chemical technologies, impacting on neural interfaces, to enhance life for humanity by the International Neuromodulation Society (INS).

Track 30: Cerebral Blood Flow and Metabolism

The brain is one of the most active organs in the body metabolically. The brain stores no excess energy and derives almost all its energy requirements from aerobic glucose oxidation. It thus calls for continuous glucose and oxygen supply to comply with its energy demands. In most of the organ of the body, blood flow is closely associated with the metabolism of the tissue. An increase in tissue metabolism, such as during muscle contraction or changes in brain neural activity, leads to increased blood flow (active hyperemia).

Neurochemistry and Neuropharmacology helps in finding the affect cellular function in the nervous system and the neural mechanisms through which they influence behavior. There are two main divisions of neuropharmacology are behavioral and molecular. Behavioral neuropharmacology emphases on the learning of how drugs affect human behavior (neuro psychopharmacology), including the learning of how drug dependence and obsession affect the human brain. Molecular neuropharmacology includes the learning of neurons and their neurochemical interactions, with the overall aim of developing drugs that have beneficial effects on neurological function.

NEUROPHARMACEUTICS 2021 focuses on wide-ranging array of disorders and cure of brain and connecting neurons. According to the newest survey led by WHO, it is shown that Neurological Disorders about Stroke, Alzheimer & Dementia, Epilepsy and many more accounts for more than 12% of deaths global on an average and it is also forecast that the number of disability –adjusted life years disappeared due to Neurological disorders are projected to accelerate from 95 million globally in 2015 to 103 million by 2030.Moreover, the global cost of neurological squeal solitary projected in 2010 was US$ 2.5 trillion and it is expected that the value will spike to over US$ 6 trillion by 2030.

Alzheimer's Research UK presently funds 150 research projects across the UK and has dedicated nearly £40million to dementia research. Their research will help in improving the quality of life of those already living with Alzheimer’s disease and other forms of dementia.

The Alzheimer's Association funds independent investigators worldwide, they have awarded over $335 million to more than 2,250 projects. Research led by the Alzheimer's Society, displays that there will be 850,000 people living with dementia in the UK by 2015. This will budget the UK £26 billion a year.

National Alliance got fund of $650 million to fuel the research on mental illness. NARSAD Young Investigator Grant delivers $30,000 per year on research in Neural and behavior disorders such as schizophrenia, mood disorders, anxiety disorders, or child and adolescent mental illnesses. Brain tumor research gets less than 1% (0.7%) of national cancer research spending in the UK.

The number of people living in the UK with neurological conditions is reported by the specialist organizations as follows:

Parkinson’s disease - 120,000
Multiple sclerosis - 100,000
Huntington’s disease - 6,500-8,000
Motor neuron disease - 5,000
Progressive supranuclear palsy - 4,000-10,000
Multiple system atrophy - 3,000

Major Associations around the World:

Neuropathy Association
The brain & behavior research foundation
Alzheimer's Association
American Academy of Neurology
European Neurological Societies
World Federation of Neurology
Spanish Society of Neurology
Major Neurological Associations in Italy
Hilarescere Foundation in Italy
Italian MS society in Italy
Southern Clinical Neurological Society
ESNR European Society of Neuroradiology

The worldwide neuroscience market size was prized at USD 28.42 billion in 2016 and is projected to grow at a CAGR of 3.1% over the forecast period. High prompting factors are on-going brain mapping research and analysis projects, neuroscience-based projects by government bodies, and technological advances in tools and algorithms that are used in neuroscience space, are estimated to boost the market growth.

Market size by technology 2012-2020 (USD Million)

Regional Market growth of Neuroscience:
North America took the largest share in 2016 as regional market. Key factors that are recognized to this large share are presence of a substantial number of neuroscience-based research entities, funding by government & other organizations, and availability of well-built healthcare systems along with rising popularity of neurological disorders in the region. When we compare China and Japan, Asia Pacific is estimated to arise as the fastest growing regional market owing to the owing to constantly improving healthcare system and presence of important target population in the region.

Report Scope
The validation of this report is wide and covers therapeutics used in treatment of neurological disorders. The report highlights the recent and upcoming market potential of neurology medicines and delivers a detailed analysis of the competitive environment, regulations, epidemiology of neurological diseases, merger and acquisition, drivers, restraints, and pipeline drugs in the market. The report also addresses market forecasts by 2024.

The report describes neurology's market share based on various indications of disease. The market is divided into Parkinson's diseases, Alzheimer's conditions, psychotic disorder, epileptic disorders, and autism and brain tumor disorders on the basis of neurological disorders. The therapy and regional analysis cover each segment of disease.

The Parkinson Diseases market includes anti-Parkinson medicines. The market is divided into the class and region of drugs. Dopamine inhibitors, dopamine agonists and other medicines from Anti-Parkinson are the market segmented based on the drug class. The North American, Europe, Asia-Pacific, South America and the Middle East and the Africa segmentation market is based on the region.

The Alzheimer's market includes Alzheimer's medicines. The market is divided into a drug and region mechanism. The Ache inhibitors and NMDA antagonists are segmented on the basis of drug class. The North America, Europe and the rest of the world market is segmented on a regional basis.

The market of psychotic diseases covers antipsychotic drugs. The market is segmented into drug class and region. Based on drug, the market is segmented into D2 antagonists, D2/5HT2A antagonists, and D2 partial agonist. Based on region the market is segmented into North America, Europe, Asia-Pacific, South America and Middle East and Africa.

Anti-epileptic medicines are part of the market for epileptic diseases. The market is divided into the class and region of drugs. The market is divided into drugs of 1st generation, medicinal products of 2nd generation and drugs of 3rd generation. The North American, Europe, Asia-Pacific, South America and the Middle East and the Africa segmentation market is based on the region.

The autism disorder market encompasses the treatment of autism disorders. The market is divided into drugs based on information and region labelling. The market is divided into pharmaceuticals and pharmaceuticals labelled as ASD based on the drug class. The market in North America, Europe and the rest of the countries is based in the region.

The brain tumor market includes the treatment of brain tumors. The market is divided into therapy and area. The market is divided into chemotherapy and targeted therapy based on the type of therapy. The North America, Europe, Asia-Pacific and the rest of the World market segment on a regional basis.

Data for 2018 as base year and forecasts 2019-2024 will be provided for market estimates. The values estimated are based on total income from drug manufacturers. Unadjusted for inflation, the forecast and forecast revenue values are constant US dollars.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 13-14, 2022
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

27^th International Conference on Neuropharmacology and Neurochemistry June 13-14, 2022 Amsterdam, Netherlands

Recommended Global Pharma Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Neuropharmaceutics 2022

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues